Oppenheimer Asset Management Inc. Sells 9,759 Shares of Definitive Healthcare Corp. (NASDAQ:DH)

Oppenheimer Asset Management Inc. decreased its position in shares of Definitive Healthcare Corp. (NASDAQ:DH) by 19.8% during the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 39,634 shares of the company’s stock after selling 9,759 shares during the quarter. Oppenheimer Asset Management Inc.’s holdings in Definitive Healthcare were worth $216,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors have also recently made changes to their positions in the company. Susquehanna Fundamental Investments LLC purchased a new stake in shares of Definitive Healthcare during the first quarter valued at approximately $120,000. Vanguard Group Inc. boosted its holdings in Definitive Healthcare by 1.5% in the first quarter. Vanguard Group Inc. now owns 4,535,377 shares of the company’s stock worth $36,600,000 after purchasing an additional 67,068 shares during the last quarter. Boston Partners bought a new stake in Definitive Healthcare in the 1st quarter worth approximately $550,000. Swiss National Bank grew its position in Definitive Healthcare by 2.9% in the 1st quarter. Swiss National Bank now owns 103,300 shares of the company’s stock worth $834,000 after purchasing an additional 2,900 shares during the period. Finally, Comerica Bank grew its position in Definitive Healthcare by 9.3% in the 1st quarter. Comerica Bank now owns 436,831 shares of the company’s stock worth $3,525,000 after purchasing an additional 37,044 shares during the period. Hedge funds and other institutional investors own 98.67% of the company’s stock.

Analyst Upgrades and Downgrades

A number of research firms have commented on DH. Needham & Company LLC reaffirmed a “hold” rating on shares of Definitive Healthcare in a research report on Tuesday, August 6th. Deutsche Bank Aktiengesellschaft cut their target price on shares of Definitive Healthcare from $7.00 to $5.00 and set a “hold” rating for the company in a research report on Friday, August 9th. JPMorgan Chase & Co. downgraded shares of Definitive Healthcare from a “neutral” rating to an “underweight” rating and cut their target price for the stock from $7.00 to $5.00 in a research report on Wednesday, July 31st. BTIG Research began coverage on shares of Definitive Healthcare in a research report on Tuesday, September 17th. They issued a “buy” rating and a $7.00 target price for the company. Finally, Stifel Nicolaus cut their price objective on shares of Definitive Healthcare from $9.50 to $7.50 and set a “buy” rating for the company in a research report on Wednesday, July 31st. One research analyst has rated the stock with a sell rating, seven have given a hold rating and three have assigned a buy rating to the company’s stock. According to MarketBeat, the stock has an average rating of “Hold” and a consensus target price of $5.81.

Definitive Healthcare Trading Down 6.4 %

Shares of DH stock opened at $4.50 on Monday. Definitive Healthcare Corp. has a 1 year low of $3.19 and a 1 year high of $10.62. The firm has a fifty day moving average price of $4.62 and a 200-day moving average price of $5.84. The company has a debt-to-equity ratio of 0.27, a current ratio of 2.40 and a quick ratio of 2.40. The company has a market cap of $530.71 million, a price-to-earnings ratio of -2.57, a PEG ratio of 6.38 and a beta of 1.33.

Definitive Healthcare (NASDAQ:DH) last issued its earnings results on Monday, August 5th. The company reported $0.09 earnings per share for the quarter, hitting the consensus estimate of $0.09. The company had revenue of $63.70 million during the quarter, compared to the consensus estimate of $63.19 million. Definitive Healthcare had a negative net margin of 156.65% and a positive return on equity of 0.98%. Definitive Healthcare’s quarterly revenue was up 4.4% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $0.08 EPS. As a group, equities analysts predict that Definitive Healthcare Corp. will post 0.07 earnings per share for the current year.

Definitive Healthcare Company Profile

Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution.